TransCode Therapeutics (NASDAQ:RNAZ) Stock Rating Lowered by Wall Street Zen
TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Separately, HC Wainwright cut their price target on shares of TransCode Therapeutics from $560.00 to $280.00 and set a “buy” rating on the stock […]
TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Separately, HC Wainwright cut their price target on shares of TransCode Therapeutics from $560.00 to $280.00 and set a “buy” rating on the stock […]
